Solventum Corp.

Healthcare · Medical Instruments & Supplies

88.80$ +1.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Solventum Corp. (SOLV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,209 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SOLV
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,074	2,036	2,016	2,081	2,082	2,075	2,070	2,161	2,096	1,998	2,007	2,209	8,310
Cost of Revenue	865	878	844	944	917	956	956	986	919	1,013	910	923	3,765
Gross Profit	1,209	1,158	1,172	1,137	1,165	1,119	1,114	1,175	1,177	985	1,097	1,286	4,545
Research & Development	180	190	195	192	189	199	193	189	183	176	189	178	726
Selling, General & Administrative	581	575	596	701	701	784	769	772	780	759	827	927	3,293
Total Operating Expenses	705	752	791	893	890	983	962	961	1,040	-693	1,016	1,105	2,468
Operating Income	504	406	381	244	275	136	152	214	137	1,678	81	181	2,077
Interest Expense	0.0	–	39	114	107	107	104	103	89	51	62	64	266
Pre-Tax Income	500	391	329	96	167	13	38	103	1,514	58	16	108	1,696
Income Tax Expense	40	119	92	7.0	45	-17	-99	13	248	-5.0	3.0	15	261
Net Income	460	272	237	89	122	31	137	90	1,266	63	13	92	1,434
EBITDA	644	530	507	343	407	270	271	328	1,724	489	213	172	2,598

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings